ArticleCerebellum (London, England)2026
Patient-Reported Visual Function in Ataxias and Association with Clinical Oculomotor Findings.
Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oculomotor dysfunction is common in ataxias, but its impact on patient-reported visual function remains insufficiently understood. To characterize patient-reported visual function across ataxias and assess the functional significance of specific oculomotor abnormalities in spinocerebellar ataxias. Participants were recruited at Massachusetts General Hospital (n = 117): 56 with genetically-defined ataxias (SCA2, SCA3, SCA6, SCA27B, CANVAS), and 61 controls. Patient-reported visual function was assessed using a 13-item subset of the Visual Activities Questionnaire targeting depth perception, visual acuity/spatial vision, and visual processing speed. Clinical oculomotor assessments focused on four domains: abnormal eye movements at rest, gaze-evoked nystagmus, ocular pursuit abnormalities, and dysmetria of saccades. Clinical severity was assessed with the Brief Ataxia Rating Scale and Modified International Cooperative Ataxia Rating Scale, and subjective symptoms with PROM-Ataxia. Group comparisons, correlations, and regression analyses were performed. All ataxia groups reported significantly worse visual function than controls, with the largest deficits in visual processing speed. Compared with age-matched controls, SCA3 and SCA6 individuals had significantly greater functional impairment across all subcategories. In ataxias, visual function correlated moderately with PROM-Ataxia and weakly with clinical oculomotor scores. Gaze-evoked nystagmus was the only oculomotor sign independently associated with reduced visual function. Ataxias are associated with substantial visual impairment, particularly in visual processing speed. Gaze-evoked nystagmus predicts reduced visual function in ataxias, highlighting the functional relevance of fixation instability. Patient-reported measures of visual function and oculomotor assessments are essential for capturing visual disability in clinical care and trials.
Indexed as
Identifiers
42474884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.